Be the first to like this
1. Production, marketing and distribution of the TLC-1000 and TLC-2000 Theralase Superpulsed Laser Technology for sale to healthcare practitioners nationally and internationally, interested in the safe and effective treatment of neuromuscular skeletal conditions through the elimination of pain and inflammation and the accelerated regeneration of tissue.
2. Commercialization of the patented TLC-3000 Laser and Photo Dynamic Compound Technology platform through preclinical research, FDA clinical trials and new technology development in the direct destruction of cancers for oncological applications and in the destruction of bacteria for sterilization of medical and food processing facilities.